Eileen P. Treacy
Papers
2
Total Citations
56
H-Index
2
About
Eileen P. Treacy is a leading researcher in the field of inborn errors of metabolism, with a particular focus on classical galactosaemia. Her work has fundamentally advanced the understanding of this rare but serious genetic disorder, which impairs the body's ability to metabolize galactose. Treacy's major contributions center on the role of glycosylation—specifically, the abnormal processing of N-glycans on immunoglobulin G (IgG). Her landmark 2016 study, cited 46 times, provided novel insights into how galactosaemia disrupts IgG N-glycosylation and N-glycan biosynthesis, revealing a potential biomarker for the disease's long-term complications. Building on this, her 2015 paper established IgG N-glycosylation galactose incorporation ratios as a powerful tool for monitoring disease progression and treatment efficacy. These findings have not only deepened the mechanistic understanding of galactosaemia but also opened new avenues for clinical management. Treacy’s work is highly regarded for bridging basic biochemistry with translational medicine, offering hope for improved outcomes in patients who often suffer from neurological and ovarian dysfunction despite dietary restrictions. Her research continues to shape the landscape of metabolic disease investigation.
Research Focus
Key Achievements
Top Papers
- 1
- 2